In focus · trending topic

nitric oxide

34 stories · following the connections

Novan Advances Organization and Strengthens Leadership Team

By Nasdaq OMXApr 12, 2018, 11:05 AM UTC

Novan Announces Corporate Update Conference Call and Webcast

By Nasdaq OMXMar 29, 2018, 12:05 PM UTC

Dr. Eugene Sun Appointed to Novan Board of Directors

By Nasdaq OMXFeb 21, 2018, 1:02 PM UTC

Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne

By Nasdaq OMXFeb 13, 2018, 1:05 PM UTC

Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206

By Nasdaq OMXJan 25, 2018, 2:01 PM UTC

Novan Announces Closing of Offering of Common Stock and Warrants

By Nasdaq OMXJan 11, 2018, 2:15 PM UTC

Novan to Present Positive Phase 2 Results for SB208 Antifungal Program at Winter Clinical Dermatology Conference

By Nasdaq OMXJan 11, 2018, 2:10 PM UTC

Novan Announces Pricing of $38.0 Million Offering of Common Stock and Warrants

By Nasdaq OMXJan 5, 2018, 2:01 PM UTC